PALISADE BIO, INC. — Director's Dealing 2014

Jul 31, 2014

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Neuralstem, Inc. (CUR)
CIK: 0001357459
Period of Report: 2014-01-13

Reporting Person: Sohn Catherine A. (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	25000	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Common Stock Purchase Option	$3.33	2021-01-13	Common Stock (15000)		Direct

Footnotes

F1: Represents Restricted Stock Unit ("RSU") pursuant to the Issuer's 2010 compensation plan. The RSU's vest as follows: (i) 12,500 upon the one month anniversary of joining the Board, and (ii) 12,500 shall vest quarterly over a one year period commencing on January 13, 2014, the date Reporting Person joined the Board. If the vesting conditions are satisfied, each RSU entitles the holder to one share of the Issuer's common stock for each RSU granted.

F2: Represents compensatory Committee Grant for service on the Issuer's: (i) audit, (ii) Compensation, and (iii) Governance and Nominating Committees.

F3: The options vest quarterly over the grant year commencing on January 13, 2014, the grant date.)